**Core Concept:** Benign liver tumors can be broadly classified into two types: hepatocellular and non-hepatocellular. Hepatocellular tumors are derived from liver cells, while non-hepatocellular tumors are not. Hepatocellular tumors are further categorized into two types: well-differentiated and poorly differentiated. Well-differentiated tumors are more likely to be benign, while poorly differentiated tumors are more likely to be malignant. Hepatocellular adenoma is a benign tumor that typically presents in females on oral contraceptive therapy.

**Why the Correct Answer is Right:** Hepatocellular adenomas are benign liver tumors that originate from liver cells. They are more common in females on oral contraceptive therapy due to the effect of estrogen on the liver. The correct answer, hepatocellular adenoma, aligns with the understanding of benign liver tumors and their association with hormonal factors.

**Why Each Wrong Option is Incorrect:**
A. Hepatocellular carcinoma (HCC) is a malignant liver tumor, derived from liver cells, and not a correct answer.
B. Angiomyolipoma is a benign tumor of smooth muscle and fat cells in the kidney, not the liver.
C. Cholangiocarcinoma is a malignant tumor originating from bile duct cells, not a correct answer for benign liver tumors.
D. Hemangioma is a benign tumor consisting of blood vessels, but it is not a liver tumor; it occurs in various organs, including the liver.

**Clinical Pearl:** Hepatocellular adenoma is a significant consideration in the differential diagnosis of liver lesions, especially in females on hormonal therapy. Liver imaging studies such as ultrasound and MRI are essential for diagnosis and monitoring these patients. Monitoring is crucial due to the risk of spontaneous hemorrhage, which can be life-threatening. Additionally, oral contraceptive therapy should be discontinued to prevent further growth and complications.